Instil Bio Inc. (TIL NASDAQ) stock market data APIs
$8.0968
0.06(0.7%)
as of May 8, 2026
Try our APIs with
free plan!
Instil Bio Inc. Financial Data Overview
Price chart is built with
Anychart
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Prev. Close
8.0968
Open
8.1196
High
8.2463
Low
8.0224
52 wk Range
5.67-42.79
Market Cap
55 341 K
Shares Outstanding
6 782 K
EPS
-0.97
Beta
1.946
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Instil Bio Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Instil Bio Inc. data using free add-ons & libraries
Get Instil Bio Inc. Fundamental Data
Instil Bio Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -52 373 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-27
- EPS/Forecast: -3.78
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Instil Bio Inc. News
New
Instil Bio, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 20, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Instil Bio, Inc., (“Instil" or the "Company") (NASDAQ: TIL) investors that the firm has initiated an investigation into...
Instil Bio Non-GAAP EPS of -$0.97 beats by $2.81
* Instil Bio press release [https://seekingalpha.com/pr/20453710-instil-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-corporate] (TIL [https://seekingalpha.com/symbol/...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL). Such investors are ...
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
On February 2, BML Capital Management, LLC disclosed a new position in CarMax(NYSE:KMX), acquiring 155,000 shares in an estimated $5.99 million trade based on quarterly average pricing. What happened...
Get Instil Bio Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
